Home > Healthcare > Medical Devices > Implantable Devices > Iliac Stents Market

Iliac Stents Market Size

  • Report ID: GMI8576
  • Published Date: Mar 2024
  • Report Format: PDF

Iliac Stents Market Size

Iliac Stents Market size was valued at around USD 899.9 million in 2023 and is expected to grow at a CAGR of 5% between 2024 and 2032. The increasing prevalence of peripheral artery disease (PAD) is anticipated to be among the primary factors to fuel the market growth.

 

The increasing prevalence of peripheral artery disease (PAD) is contributing to the growing demand for iliac stents. As the population ages and risk factors such as diabetes, obesity, and smoking become more prevalent, the incidence of PAD is on the rise. More people are experiencing symptoms related to PAD, such as leg pain, cramping, and difficulty walking, which can significantly impact their quality of life.

 

For instance, according to the Centers for Disease Control and Prevention (CDC), the number of people affected by peripheral artery disease (PAD) in the U.S. is approximately 6.5 million people aged 40 and older. This condition primarily affects African American individuals, with similar or slightly higher rates for Hispanics compared to non-Hispanic white people. This rising prevalence of PAD necessitates highly accurate treatment procedures and related devices, thereby anticipating an increasing demand for iliac stents.
 

Iliac stents are medical devices used to treat blockages or narrowing (stenosis) in the iliac arteries, which are located in the pelvis and supply blood to the legs. The iliac stent is a small, mesh-like tube made of metal, usually stainless steel or nitinol that is inserted into the narrowed artery to hold it open.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Iliac stents market size was USD 899.9 million in 2023 and is expected to register 5% CAGR from 2024-2032 owing to the increasing prevalence of peripheral artery disease (PAD) worldwide.

The balloon-expandable iliac segment and is expected to register 5.2% CAGR from 2024-2032 due to their familiarity with the deployment technique and perceived ease of use compared to other type of stents.

North America iliac stents industry reached USD 216.8 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to increasing awareness among patients and healthcare providers about vascular diseases and available treatment options in the region.

Abbott Laboratories, Alvimedica, Becton, Dickinson and Company, Biotronik, Boston Scientific Corporation, B. Braun SE, Cook, Getinge AB, iVascular, and Medtronic Plc, are some of the major iliac stents companies worldwide.

Iliac Stents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 189
  • Countries covered: 22
  • Pages: 110
 Download Free Sample